4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000068
Chief Operating Officer sold 13,449 shares at an average $17.92 ($240,941)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-18 | Sale : show line 1 in the form 10b5-1 | −12,153 | $17.84 | $216,810 | 228,100 | D |
| 2024-03-18 | Sale : show line 2 in the form 10b5-1 | −1,296 | $18.62 | $24,132 | 226,804 | D |
| Open-market sales · 13,449 sh · avg $17.92 · $240,941 | ||||||
Loading xslF345X05/wk-form4_1710965959.xml…